-transparent.png){kind=logo}
A double-blind crossover trial was carried out in 15 patients with definite rheumatoid arthritis to compare the effectiveness of 1200 mg azapropazone daily and 750 mg naproxen daily, each drug being given for 2 weeks. Patients also received placebo therapy before and between the two treatment periods. The results of subjective and objective assessments showed that both drugs were significantly superior to placebo, but no significant difference could be demonstrated between the two drugs.
Related Publications
H A Capell, and
M M McLeod, and
L A Hernández, and
D M Grennan, and
J S Templeton
September 1985,
Clinical rheumatology,
H A Capell, and
M M McLeod, and
L A Hernández, and
D M Grennan, and
J S Templeton
January 1980,
The Journal of rheumatology. Supplement,
H A Capell, and
M M McLeod, and
L A Hernández, and
D M Grennan, and
J S Templeton
January 1978,
Rheumatology and rehabilitation,
H A Capell, and
M M McLeod, and
L A Hernández, and
D M Grennan, and
J S Templeton
March 1978,
Archives of internal medicine,
H A Capell, and
M M McLeod, and
L A Hernández, and
D M Grennan, and
J S Templeton
January 1976,
Current medical research and opinion,
H A Capell, and
M M McLeod, and
L A Hernández, and
D M Grennan, and
J S Templeton
November 1981,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
H A Capell, and
M M McLeod, and
L A Hernández, and
D M Grennan, and
J S Templeton
January 1977,
The Journal of international medical research,
H A Capell, and
M M McLeod, and
L A Hernández, and
D M Grennan, and
J S Templeton
January 1974,
Current medical research and opinion,
H A Capell, and
M M McLeod, and
L A Hernández, and
D M Grennan, and
J S Templeton
March 1984,
The British journal of clinical practice,
H A Capell, and
M M McLeod, and
L A Hernández, and
D M Grennan, and
J S Templeton
October 1977,
The Journal of the Association of Physicians of India,
